Overview
Rebecca Brady is a Palliative Medicine provider in Hackensack, New Jersey. Her top area of expertise is ALK-Positive Non-Small Cell Lung Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
20 Prospect Avenue, Suite 602, Hackensack, NJ 7601.
Paul Glare is a Palliative Medicine provider in New York, New York. Dr. Glare is highly rated in 1 condition, according to our data. His top area of expertise is Chronic Pain.
Icahn School Of Medicine At Mount Sinai
Christie Mulholland is a Palliative Medicine provider in New York, New York. Dr. Mulholland is highly rated in 1 condition, according to our data. Her top area of expertise is Opioid Induced Constipation.
Icahn School Of Medicine At Mount Sinai
Joanna Chen is a Palliative Medicine provider in Astoria, New York. Dr. Chen is highly rated in 1 condition, according to our data. Her top area of expertise is Opioid Induced Constipation.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ALK-Positive Non-Small Cell Lung Cancer